Skip to content

Development of novel biomarkers for inflammatory bowel disease using HPLC

Development of novel biomarkers for inflammatory bowel disease using HPLC - HPLCIBDBM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033367
Enrollment
50
Registered
2018-07-17
Start date
2018-07-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis Crohn&#39

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Crohn's disease patients Ulcerative colitis patients

Exclusion criteria

Exclusion criteria: Those who judged unsuitable

Design outcomes

Primary

MeasureTime frame
Development of novel biomarkers for diagnosis of inflammatory bowel disease

Countries

Japan

Contacts

Public ContactSatoko Umeda

Keio University Gastroenterology department

satokoumeda@keio.jp0353633790

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026